Newsletters

Summer 2006

Why Volunteer for a Clinical Research Trial?

Part I of a II Part Series (Read Part II)

New Mexico Clinical Research & Osteoporosis Center con-ducts pharmaceutical sponsored trials. Phase II trials evaluate the effectiveness and safety of experimental drugs or treatments involving large groups of people (100-300). Phase III trials study experimental drugs or treatments on larger groups of people (1,000-3,000). Both phases confirm effectiveness, monitor side effects, sometimes make comparisons to commonly used treatments, and collect information on the safety of drugs and treatments under study. Our dedicated clinical team of doctors and research professionals monitor participants carefully during the trial and if necessary, remain in contact with them after completion.

Should You Participate in a Clinical Research Trial?

As a volunteer in a clinical research trial you not only take on an active role in your own health care but are participating in the development of medical therapies that may offer better treatments and cures for diseases. Gaining access to new research treatments before they become publicly available could provide you with medical treatment for that does not currently exist and may ultimately improve the medical care you receive.

Whatever reason you chose to participate in clinical research, be assured that you are engaging in the advancement of medical treatments for chronic or life-threatening diseases.

Are Clinical Research Trials Monitored?

Every clinical trial in the US must be approved and monitored by an Independent Review Board (IRB) to make sure the risks are minimal and are worth the potential benefits. An IRB is an independent committee of ethical physicians, statisticians, and community advocates whose prime endeavor is to safeguard and protect the rights of the participants. We work closely with our IRB’s to assure your safety and confidentiality.